Ontology highlight
ABSTRACT: Background and objectives
The significance of persistent hematuria or proteinuria in patients with ANCA-associated vasculitis who are otherwise in clinical remission is unclear.Design, setting, participants, & measurements
A post hoc analysis was conducted using participants enrolled in two randomized, placebo-controlled clinical trials who had active GN due to ANCA-associated vasculitis, had positive ANCA, and achieved remission by month 6. Dipstick and microscopic urinalyses were performed at each visit. Persistent hematuria or proteinuria for at least 6 months and the cumulative duration of hematuria were examined. Renal relapse was defined as new or worsening red blood cell casts and/or worsening kidney function according to the Birmingham Vasculitis Activity Score for Granulomatosis with Polyangiitis.Results
There were 149 patients included in this study: 42% had persistent hematuria, and 43% had persistent proteinuria beyond 6 months. Persistent hematuria was associated with a significantly higher risk of relapse, even after adjusting for potential confounders (subdistribution hazard ratio, 3.99; 95% confidence interval, 1.20 to 13.25; P=0.02); persistent proteinuria was not associated with renal relapse (subdistribution hazard ratio, 1.44; 95% confidence interval, 0.47 to 4.42; P=0.53). Furthermore, greater cumulative duration of hematuria was significantly associated with a higher risk of renal relapse (adjusted subdistribution hazard ratio, 1.08 per each month; 95% confidence interval, 1.03 to 1.12; P<0.01). The median time to renal relapse was 22 months.Conclusions
In patients with ANCA-associated vasculitis and kidney involvement who achieve remission after induction therapy, the presence of persistent hematuria, but not proteinuria, is a significant predictor of future renal relapse.
SUBMITTER: Rhee RL
PROVIDER: S-EPMC5967421 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
Rhee Rennie L RL Davis John C JC Ding Linna L Fervenza Fernando C FC Hoffman Gary S GS Kallenberg Cees G M CGM Langford Carol A CA McCune W Joseph WJ Monach Paul A PA Seo Philip P Spiera Robert R St Clair E William EW Specks Ulrich U Stone John H JH Merkel Peter A PA
Clinical journal of the American Society of Nephrology : CJASN 20180125 2
<h4>Background and objectives</h4>The significance of persistent hematuria or proteinuria in patients with ANCA-associated vasculitis who are otherwise in clinical remission is unclear.<h4>Design, setting, participants, & measurements</h4>A <i>post hoc</i> analysis was conducted using participants enrolled in two randomized, placebo-controlled clinical trials who had active GN due to ANCA-associated vasculitis, had positive ANCA, and achieved remission by month 6. Dipstick and microscopic urinal ...[more]